By Eric Schweibenz
On December 17, 2013, ALJ Theodore R. Essex issued Order No. 40 in Certain Omega-3 Extracts from Marine or Aquatic Biomass and Products Containing the Same (Inv. No. 337-TA-877).

According to the Order, ALJ Essex granted Complainants Neptune Technologies & Bioressources Inc. and Ascati Pharma Inc. and Respondents Aker BioMarine AS, Aker BioMarine Antarctic AS, and Aker BioMarine Antarctic USA, Inc.’s (collectively, the “Aker Respondents”) joint motion to terminate the investigation as to the Aker Respondents on the basis of a settlement agreement reached between the parties.